Jason Leider | HIV & Diabetes | Innovative Research Award

Innovative Research Award

Jason Leider
Affiliation Physician Affiliate Group of New York
Country United States
Scopus ID 55193803000
Documents 36
Citations 953
h-index 19
Subject Area HIV & Diabetes
Event Global Genetics Awards

Jason Leider
Physician Affiliate Group of New York

Jason Leider is a physician-scientist whose published research has addressed HIV testing, linkage to care, HIV/HCV coinfection, and clinical and public-health questions involving people living with HIV. His documented research record includes collaborative studies conducted through academic and public-health settings, with publications appearing in peer-reviewed medical journals. [2] [3]

Abstract

Jason Leider’s research record reflects sustained involvement in HIV medicine and related clinical and public-health research. Available publications document work on HIV testing in emergency-department environments, strategies for connecting HIV-positive individuals with specialized care, HIV/HCV coinfection, and barriers affecting HIV treatment and care. [2] [3] [4] His collaborative publications illustrate an applied research orientation in which clinical investigation is connected with patient engagement, healthcare access, testing strategies, and population health. [5]

Keywords

  • Jason Leider
  • Innovative Research Award
  • HIV research
  • HIV testing
  • HIV linkage to care
  • HIV/HCV coinfection
  • Clinical research
  • Public-health research
  • Emergency-department testing

Introduction

Research on HIV has increasingly incorporated clinical medicine, epidemiology, health services research, and implementation-oriented approaches. Within this broader field, HIV testing and linkage to appropriate care are important components of effective clinical and public-health systems. Leider has contributed to this area through studies examining testing practices and the transition of patients from diagnosis toward specialized HIV care. [2] [5]

Published work involving Leider also demonstrates attention to the intersection of HIV with other infectious and chronic health conditions. Research on HIV/HCV coinfection has considered clinical-management challenges and patient experiences, while later collaborative work has examined HIV diagnosis and clinical outcomes in the context of the COVID-19 pandemic. [4] [6] This multidisciplinary orientation provides a relevant foundation for recognition within an award category focused on innovative research.

Research Profile

The supplied research profile identifies HIV and diabetes as the principal subject area. The available bibliographic record, however, more directly documents Leider’s research activity in HIV medicine, HIV testing, linkage to care, HIV/HCV coinfection, and related clinical research. Accordingly, the profile is best interpreted as an interdisciplinary clinical-research portfolio rather than as a claim that every publication specifically addresses diabetes.

The supplied Scopus metrics comprise 36 documents, 953 citations, and an h-index of 19. [1] These indicators provide quantitative context for the visibility of the research record, while individual publications provide qualitative evidence of the problems addressed and the clinical settings in which the work has been conducted.

Research Contributions

Several themes characterize the documented research contributions associated with Jason Leider:

  • HIV testing: Research has examined operational and patient-oriented approaches to HIV testing in emergency-department settings, including the use of structured approaches to increase access to testing.
  • Linkage to HIV care: Leider has contributed to research evaluating methods for connecting individuals with positive HIV tests to specialized medical services after diagnosis. [2]
  • HIV/HCV coinfection: Collaborative research has investigated healthcare challenges affecting patients with HIV and hepatitis C virus coinfection, including clinical and psychosocial dimensions. [4]
  • Integrated infectious-disease testing: Leider participated in a randomized controlled trial examining bundled HIV and HCV testing in emergency-department care. [3]
  • Contemporary clinical research: His later collaborative work included investigation of HIV diagnosis and clinical outcomes among patients seeking care during the initial COVID-19 pandemic period in New York City’s public hospital system. [6]

Publications

The following selected publications illustrate the research themes documented in publicly accessible scholarly records. The list is representative rather than exhaustive and should not be interpreted as a complete bibliography.

  1. Leider, J., Fettig, J., & Calderon, Y. Engaging HIV-positive individuals in specialized care from an urban emergency department. AIDS Patient Care and STDs, 25(2), 89–93.
  2. Cowan, E., Herman, H. S., Rahman, S., Zahn, J., Leider, J., & Calderon, Y. Bundled HIV and Hepatitis C Testing in the Emergency Department: A Randomized Controlled Trial. Western Journal of Emergency Medicine, 19(6), 1049–1056.
  3. Lekas, H.-M., Siegel, K., & Leider, J. Challenges facing providers caring for HIV/HCV-coinfected patients. Qualitative Health Research, 22(1), 54–66.
  4. Kaplan-Lewis, E., Banga, J., Khan, M., et al., including Leider, J. HIV Diagnosis and the Clinical Course of COVID-19 Among Patients Seeking Care Within the New York City Public Hospital System During the Initial Pandemic Peak. AIDS Patient Care and STDs, 35(12). [6]
  5. Mohammed, D. Y., Brewer, R., Leider, J., Martin, E., & Choe, S. Barriers to HIV rapid start among New Jersey providers. HIV Research & Clinical Practice, 25(1), 2402140.

Research Impact

The supplied bibliometric profile reports 953 citations and an h-index of 19, indicating measurable scholarly uptake of the research record. [1] Beyond citation metrics, the documented publications address practical questions concerning HIV testing, linkage to specialized care, integrated infectious-disease testing, and healthcare delivery. Such research can contribute to clinical and public-health discussions by examining how evidence-based testing and care pathways operate in real-world healthcare settings.

The research portfolio also demonstrates collaboration across medical, epidemiological, and public-health disciplines. Studies involving emergency departments, HIV services, and public hospital systems illustrate an applied orientation toward questions that connect research findings with healthcare implementation. [2] [3] [6]

Award Suitability

For an Innovative Research Award, the documented record provides several relevant considerations. First, the research addresses clinically important HIV-related questions using observational, qualitative, prospective, and randomized study approaches. [2] [3] Second, the work emphasizes practical aspects of healthcare delivery, including testing and linkage to care. Third, the publication record demonstrates collaborative engagement across institutions and professional disciplines.

The award assessment should nevertheless distinguish documented evidence from promotional interpretation. Bibliometric indicators such as citations and h-index are useful measures of scholarly visibility but do not independently establish research quality or innovation. A complete award evaluation would therefore consider the originality of individual contributions, methodological rigor, significance of findings, reproducibility, leadership, and broader influence alongside bibliometric evidence.

Conclusion

Jason Leider’s documented research profile reflects sustained scholarly engagement with HIV medicine, testing, linkage to care, HIV/HCV coinfection, and related clinical and public-health questions. His publications demonstrate an applied research approach that connects clinical investigation with healthcare delivery and patient access. [2] [3] The supplied Scopus metrics of 36 documents, 953 citations, and an h-index of 19 provide additional bibliometric context. [1] On the evidence documented here, his interdisciplinary and clinically oriented research record is relevant to consideration for an Innovative Research Award, subject to the formal evaluation criteria of the awarding organization.

References

  1. Elsevier. (n.d.). Scopus author details: Jason Leider, Author ID 55193803000. Scopus. Bibliometric values supplied for this profile: 36 documents, 953 citations, and h-index 19.
    https://www.scopus.com/authid/detail.uri?authorId=55193803000
  2. Leider, J., Fettig, J., & Calderon, Y. (2011). Engaging HIV-positive individuals in specialized care from an urban emergency department. AIDS Patient Care and STDs, 25(2), 89–93. DOI: https://doi.org/10.1089/apc.2010.0205
  3. Cowan, E., Herman, H. S., Rahman, S., Zahn, J., Leider, J., & Calderon, Y. (2018). Bundled HIV and Hepatitis C Testing in the Emergency Department: A Randomized Controlled Trial. Western Journal of Emergency Medicine, 19(6), 1049–1056. DOI: https://doi.org/10.5811/westjem.2018.8.37827
  4. Lekas, H.-M., Siegel, K., & Leider, J. (2012). Challenges facing providers caring for HIV/HCV-coinfected patients. Qualitative Health Research, 22(1), 54–66. DOI: https://doi.org/10.1177/1049732311418248
  5. Bauman, L. J., Braunstein, S., Calderon, Y., Chhabra, R., Cutler, B., Leider, J., Rivera, A., Sclafane, J., Tsoi, B., & Watnick, D. (2013). Barriers and facilitators of linkage to HIV primary care in New York City. Journal of Acquired Immune Deficiency Syndromes, 64(Suppl. 1), S20–S26. DOI: https://doi.org/10.1097/QAI.0b013e3182a99c19
  6. Kaplan-Lewis, E., Banga, J., Khan, M., Casey, E., Mazumdar, M., Bratu, S., Abdallah, M., Pitts, R., Leider, J., Hennessey, K., Cohen, G. M., Cleland, C. M., & Salama, C. (2021). HIV Diagnosis and the Clinical Course of COVID-19 Among Patients Seeking Care Within the New York City Public Hospital System During the Initial Pandemic Peak. AIDS Patient Care and STDs, 35(12). DOI: https://doi.org/10.1089/apc.2021.0124

Kang Yang | Metabolic Disorders | Best Researcher Award

Dr. Kang Yang | Metabolic Disorders | Best Researcher Award

Northern Jiangsu People's Hospital affiliated with Yangzhou University | China

Author Profile

Scopus

Orcid Id

EARLY ACADEMIC PURSUITS 🎓

Kang Yang embarked on his academic journey at Shandong First Medical University, where he pursued a Bachelor of Medicine (BM) in 2017 under the mentorship of Professor Jianhong Qi. His early interest in sports medicine and rehabilitation laid a strong foundation for his future contributions in the field.

Building on this, he further honed his expertise at Yangzhou University, obtaining a Master of Medicine (MM) in 2020 under the guidance of Professor Xianghe Chen. His postgraduate studies deepened his understanding of rehabilitation techniques, patient care, and innovative treatments in sports medicine.

PROFESSIONAL ENDEAVORS 💼

As a rehabilitation physician and therapist, Kang Yang is committed to enhancing the quality of life for patients recovering from injuries, surgeries, and physical impairments. His work integrates advanced rehabilitation methodologies with patient-centered approaches to ensure effective recovery and functional restoration.

Throughout his career, he has actively contributed to both clinical practice and academic research, focusing on rehabilitation strategies tailored for athletes and individuals with musculoskeletal disorders.

CONTRIBUTIONS AND RESEARCH FOCUS ON METABOLIC DISORDERS🔬

Kang Yang’s research primarily revolves around sports medicine and rehabilitation medicine. His investigations explore:

  • Innovative rehabilitation techniques for sports-related injuries.
  • Physiological and biomechanical adaptations in long-distance runners and athletes.
  • Post-injury recovery protocols aimed at optimizing healing and preventing re-injury.

His dedication to research has led to significant advancements in sports rehabilitation, with a particular focus on marathon runners and endurance athletes.

IMPACT AND INFLUENCE 🔍

Kang Yang's contributions extend beyond clinical settings. His work has influenced:

  • Rehabilitation strategies for sports professionals.
  • Medical education, through his involvement in teaching and mentoring young medical students.
  • Public awareness on the importance of injury prevention and rehabilitation in sports.

His clinical expertise and research have helped shape modern rehabilitation protocols, making a positive impact on both patient outcomes and medical practices.

ACADEMIC CITATIONS AND RECOGNITION 🏆

Kang Yang’s academic excellence has been recognized through multiple prestigious awards:

  • Special Prize (2018) & First Prize (2019) at the Jiangsu Sports Graduate Innovation Forum.
  • 2019 National Scholarship for Postgraduates (China).
  • First-class academic scholarship from Yangzhou University.

These accolades highlight his commitment to academic excellence, research innovation, and contributions to the medical community.

LEGACY AND FUTURE CONTRIBUTIONS🏰

Looking ahead, Kang Yang aims to:

  • Expand his research on sports rehabilitation and injury prevention.
  • Develop advanced therapeutic protocols for athletes and individuals recovering from physical trauma.
  • Collaborate with international experts to enhance rehabilitation medicine globally.
  • Continue mentoring students and young professionals in the field of rehabilitation sciences.

His unwavering passion and dedication position him as a future leader in the evolving landscape of sports medicine and rehabilitation.

BEYOND MEDICINE: PERSONAL INTERESTS 📚

Outside of his professional life, Kang Yang enjoys:

  • Long-distance running and marathons, reflecting his deep understanding of sports medicine from both a theoretical and practical perspective.
  • Reading, staying updated with the latest medical advancements and broadening his intellectual horizons.

NOTABLE PUBLICATIONS📑

"Exercise alleviates renal interstitial fibrosis by ameliorating the Sirt1-mediated TGF-β1/Smad3 pathway in T2DM mice

  • Authors: X., Chen, Xianghe , X., Zeng, Xinyu , X., Qiu, Xiao , X., Zhou, Xiangxiang , K., Yang, Kang
  • Journal: Endocrine Connections
  • Year: 2024

Kheireddine Ouali | Oxidative Stress and Diabetes | Best Researcher Award

Prof Kheireddine Ouali | Oxidative Stress and Diabetes | Best Researcher Award

University of Badji Mokhtar Annaba | Algeria

Author Profile

Scopus

Orcid ID

Google Scholar

Early Academic Pursuits

Kheireddine Ouali was born on December 27, 1970, in Annaba, Algeria. He pursued his early education in his hometown before embarking on higher studies. His academic journey led him to specialize in biology and animal physiology, culminating in the attainment of a Doctorat d’État.

Professional Endeavors

Currently holding the prestigious position of Professor, Kheireddine Ouali serves as both an educator and a researcher. He is based at BP12 El Hadjar Annaba 23000, Algeria, and can be reached at 038562004 or via his mobile at 0561097708. His professional responsibilities extend to his role as the Director of the Laboratory of Environmental Biosurveillance, where he oversees significant research projects and initiatives.

Contributions and Research Focus on Oxidative stress and Diabetes

Ouali's research primarily focuses on biology and animal physiology. His contributions to these fields are substantial, with numerous publications and research projects that have advanced understanding and innovation. His work is particularly noted for its emphasis on environmental biosurveillance, addressing critical issues related to environmental health and safety.

Impact and Influence

Kheireddine Ouali has made a profound impact on the scientific community, both within Algeria and internationally. His research findings and academic contributions have influenced policies and practices in environmental health. Additionally, his role as an educator has enabled him to mentor and guide the next generation of scientists and researchers.

Academic Cites

Ouali's academic work has been widely cited in various scientific journals and publications. His research on animal physiology and environmental biosurveillance is frequently referenced by peers, underscoring his influence and the importance of his contributions to these fields.

Legacy and Future Contributions

As a leading figure in his field, Kheireddine Ouali's legacy is marked by his dedication to scientific advancement and education. His future contributions are anticipated to further enhance understanding in biology, animal physiology, and environmental health, ensuring that his impact will continue to be felt for years to come.

Notable Publications

Effect of subacute treatment with bisphenol A on oxidative stress biomarkers and lipid peroxidation in Gambusia affinis mosquitofish 2023(3)

Subchronic toxicity of iron-selenium nanoparticles on oxidative stress response, histopathological, and nuclear damage in amphibian larvae Rana saharica 2023(1)

Tempol a superoxide dismutase mimic reduces cardiac muscle cell death through the control of oxidative stress in streptozotocin-induced diabetes 2023(1)

Effect of contaminated diet with a plant growth regulator “1-methylcyclopropene” on the hematological parameters and liver function of albino Wistar rats 2023(1)

In Vivo and In Silico Studies Assessment of the Effects of Oral Exposure to 1-Methylcyclopropene on Liver Function in Male Albino Rats 2024